Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Recruiting · NCT04045691 · Registry updated 2021-01-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Not stated | 2021-01-19 | NCT04045691 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pierre Fabre Pharma AG | 3 |
| Pierre Fabre Pharma Austria | 2 |
| Pierre Fabre Pharma GmbH | 3 |
59 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 1 | Buxtehude | Germany | 1 |
| 10 | Linz | Austria | 1 |
| 11 | Graz | Austria | 1 |
| 12 | Salzburg | Austria | 1 |
| 13 | Innsbruck | Austria | 1 |
| 14 | Klagenfurt | Austria | 1 |
| 15 | Mainz | Germany | 1 |
| 16 | Münster | Germany | 1 |
| 17 | Schwerin | Germany | 1 |
| 18 | Nuremberg | Germany | 1 |
| 19 | Hamburg | Germany | 1 |
| 2 | Heidelberg | Germany | 1 |
| 20 | Essen | Germany | 1 |
| 21 | Hanover | Germany | 1 |
| 22 | Vienna | Austria | 1 |
| 23 | Wiener Neustadt | Austria | 1 |
| 24 | Chur | Switzerland | 1 |
| 25 | Zurich | Switzerland | 1 |
| 26 | Winterthur | Switzerland | 1 |
| 27 | Bremerhaven | Germany | 1 |
| 28 | Giessen | Germany | 1 |
| 29 | Landshut | Germany | 1 |
| 3 | Linz | Austria | 1 |
| 30 | Ludwigshafen | Germany | 1 |
| 31 | München | Germany | 1 |